Understanding the role of social determinants on clinical trial participation and trust.
While Case Report Forms are a main contributor to collected data, non-CRF data such as core laboratory data and central imaging can be critical to any clinical study.
The data, not the plan, provide the direction.
The success of the decentralized model hinges on coordination between stakeholders across the supply chain to ensure that date is secure, medication is delivered on time, and in proper condition.
A more user-centered design can allow increased flexibility in the development of eCOA platforms, driving better engagement and participation.
Moving beyond the pill to extend the value being delivered to patients.
Clinical research evolves to prioritize patient-centered outcomes, integrating accessibility standards in electronic data capture for inclusive clinical trials.
Top predictions for the major trends that will shape clinical trial design in 2022.
The future of clinical trial design involves incorporating the patient experience into strategic asset planning.
How novel clinical trial designs can help minimize patient burden.
Clinical trial liaisons rather serve as experts in their therapeutic areas and as clinical trial specialists to provide a suite of strategic advantages to benefit a study.
The potential of next-generation platforms in transforming patient recruitment.
Minimizing impacts through focus on employee wellness.
How to leverage novel trial designs and real-world data to support a cancer drug submission with an evidence strategy that is both approvable and reimbursable.
The success of a clinical study depends on the possibilities to involve the patient in the study.
Exploring the different stages in the development of a digital measure, and the activities and steps key to achieving meaningful impact for patients.
Examining best practices in using the functional service provider model for clinical operations, pharmacovigilance, regulatory, and other areas.
Differing levels of trust in clinical trials information channels across diverse populations is examined in this research.
Best practices for assessing publications.
Meeting patients at the point of care can increase trust and engagement.
While it's important to note that there are areas where the industry can improve, there are unique opportunities of improvement for specific types of sites and the number of studies conducted there.
Study evaluates the use of AI-supported medical coding module.
Evolving mindsets are opening the door for industry to utilize new mediums for understanding patients.
Bringing some payment activities in-house while outsourcing others can help sponsors optimize clinical trial efficiency, reduce risks, and strengthen site relationships.
Harnessing these tools for successful integration and streamlining of processes.
Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.